Literature DB >> 18426907

Aberrant expression of nucleostemin activates p53 and induces cell cycle arrest via inhibition of MDM2.

Mu-Shui Dai1, Xiao-Xin Sun, Hua Lu.   

Abstract

The nucleolar protein nucleostemin (NS) is essential for cell proliferation and early embryogenesis. Both depletion and overexpression of NS reduce cell proliferation. However, the mechanisms underlying this regulation are still unclear. Here, we show that NS regulates p53 activity through the inhibition of MDM2. NS binds to the central acidic domain of MDM2 and inhibits MDM2-mediated p53 ubiquitylation and degradation. Consequently, ectopic overexpression of NS activates p53, induces G(1) cell cycle arrest, and inhibits cell proliferation. Interestingly, the knockdown of NS by small interfering RNA also activates p53 and induces G(1) arrest. These effects require the ribosomal proteins L5 and L11, since the depletion of NS enhanced their interactions with MDM2 and the knockdown of L5 or L11 abrogated the NS depletion-induced p53 activation and cell cycle arrest. These results suggest that a p53-dependent cell cycle checkpoint monitors changes of cellular NS levels via the impediment of MDM2 function.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18426907      PMCID: PMC2447154          DOI: 10.1128/MCB.01662-07

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  55 in total

Review 1.  The p53-mdm2 autoregulatory feedback loop: a paradigm for the regulation of growth control by p53?

Authors:  S M Picksley; D P Lane
Journal:  Bioessays       Date:  1993-10       Impact factor: 4.345

2.  Oncoprotein MDM2 is a ubiquitin ligase E3 for tumor suppressor p53.

Authors:  R Honda; H Tanaka; H Yasuda
Journal:  FEBS Lett       Date:  1997-12-22       Impact factor: 4.124

3.  Enhanced phosphorylation of p53 by ATM in response to DNA damage.

Authors:  S Banin; L Moyal; S Shieh; Y Taya; C W Anderson; L Chessa; N I Smorodinsky; C Prives; Y Reiss; Y Shiloh; Y Ziv
Journal:  Science       Date:  1998-09-11       Impact factor: 47.728

4.  Regulation of p53 stability by Mdm2.

Authors:  M H Kubbutat; S N Jones; K H Vousden
Journal:  Nature       Date:  1997-05-15       Impact factor: 49.962

5.  Mdm2 promotes the rapid degradation of p53.

Authors:  Y Haupt; R Maya; A Kazaz; M Oren
Journal:  Nature       Date:  1997-05-15       Impact factor: 49.962

6.  DNA damage induces phosphorylation of the amino terminus of p53.

Authors:  J D Siliciano; C E Canman; Y Taya; K Sakaguchi; E Appella; M B Kastan
Journal:  Genes Dev       Date:  1997-12-15       Impact factor: 11.361

7.  Nucleo-cytoplasmic shuttling of the hdm2 oncoprotein regulates the levels of the p53 protein via a pathway used by the human immunodeficiency virus rev protein.

Authors:  J Roth; M Dobbelstein; D A Freedman; T Shenk; A J Levine
Journal:  EMBO J       Date:  1998-01-15       Impact factor: 11.598

8.  The alternative product from the human CDKN2A locus, p14(ARF), participates in a regulatory feedback loop with p53 and MDM2.

Authors:  F J Stott; S Bates; M C James; B B McConnell; M Starborg; S Brookes; I Palmero; K Ryan; E Hara; K H Vousden; G Peters
Journal:  EMBO J       Date:  1998-09-01       Impact factor: 11.598

9.  Essential role of ribosomal protein L11 in mediating growth inhibition-induced p53 activation.

Authors:  Krishna P Bhat; Koji Itahana; Aiwen Jin; Yanping Zhang
Journal:  EMBO J       Date:  2004-05-20       Impact factor: 11.598

10.  Myc signaling via the ARF tumor suppressor regulates p53-dependent apoptosis and immortalization.

Authors:  F Zindy; C M Eischen; D H Randle; T Kamijo; J L Cleveland; C J Sherr; M F Roussel
Journal:  Genes Dev       Date:  1998-08-01       Impact factor: 11.361

View more
  101 in total

1.  Perturbation of 60 S ribosomal biogenesis results in ribosomal protein L5- and L11-dependent p53 activation.

Authors:  Xiao-Xin Sun; Yue-Gang Wang; Dimitris P Xirodimas; Mu-Shui Dai
Journal:  J Biol Chem       Date:  2010-06-16       Impact factor: 5.157

2.  Autoregulatory suppression of c-Myc by miR-185-3p.

Authors:  Jun-Ming Liao; Hua Lu
Journal:  J Biol Chem       Date:  2011-08-08       Impact factor: 5.157

3.  Ubiquitin- and MDM2 E3 ligase-independent proteasomal turnover of nucleostemin in response to GTP depletion.

Authors:  Dorothy Lo; Mu-Shui Dai; Xiao-Xin Sun; Shelya X Zeng; Hua Lu
Journal:  J Biol Chem       Date:  2012-02-08       Impact factor: 5.157

4.  Concomitant upregulation of nucleostemin and downregulation of Sox2 and Klf4 in gastric adenocarcinoma.

Authors:  Malek Hossein Asadi; Ali Derakhshani; Seyed Javad Mowla
Journal:  Tumour Biol       Date:  2014-04-25

5.  RNA content in the nucleolus alters p53 acetylation via MYBBP1A.

Authors:  Takao Kuroda; Akiko Murayama; Naohiro Katagiri; Yu-mi Ohta; Etsuko Fujita; Hiroshi Masumoto; Masatsugu Ema; Satoru Takahashi; Keiji Kimura; Junn Yanagisawa
Journal:  EMBO J       Date:  2011-02-04       Impact factor: 11.598

6.  The dynamics of the alternatively spliced NOL7 gene products and role in nucleolar architecture.

Authors:  Noa Kinor; Yaron Shav-Tal
Journal:  Nucleus       Date:  2011 May-Jun       Impact factor: 4.197

7.  A ribosomal tactic to halt cancer.

Authors:  Hua Lu
Journal:  Nat Med       Date:  2011-08-04       Impact factor: 53.440

8.  Balanced production of ribosome components is required for proper G1/S transition in Saccharomyces cerevisiae.

Authors:  Fernando Gómez-Herreros; Olga Rodríguez-Galán; Macarena Morillo-Huesca; Douglas Maya; María Arista-Romero; Jesús de la Cruz; Sebastián Chávez; Mari Cruz Muñoz-Centeno
Journal:  J Biol Chem       Date:  2013-09-16       Impact factor: 5.157

Review 9.  Probing the mechanisms underlying human diseases in making ribosomes.

Authors:  Katherine I Farley; Susan J Baserga
Journal:  Biochem Soc Trans       Date:  2016-08-15       Impact factor: 5.407

10.  IκB kinase β (IKKβ) inhibits p63 isoform γ (TAp63γ) transcriptional activity.

Authors:  Jun-Ming Liao; Yu Zhang; Wenjuan Liao; Sheyla X Zeng; Xiaohua Su; Elsa R Flores; Hua Lu
Journal:  J Biol Chem       Date:  2013-04-15       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.